Loading provider…
Loading provider…
Hematology & Oncology Physician in Santa Monica, CA
NPI: 1134153745Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get MD Edward's Phone Numberphone_androidMobile
Get MD Edward's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2003 - 2026
IL State Medical License
1999 - 2005
CA State Medical License

American Board of Internal Medicine
Medical Oncology
WashU Medicine
medicine.washu.edu
Medical School
Until 1999
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Hematology and Medical Oncology
2003 - 2006
University of Chicago
Residency • Internal Medicine
1999 - 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 68 | 133 |
| 2 | 80053Blood test, comprehensive group of blood chemicals | 66 | 130 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 66 | 153 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 48 | 97 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 38 | 39 |
Authors: Garon, Edward B, Ciuleanu, Tudor-Eliade, Arrieta, Oscar, Prabhash, Kumar, Syrigos, Konstantinos N, Goksel, Tuncay, Park, Keunchil, Gorbunova, Vera, Kowalyszyn, Ruben Dario, Pikiel, Joanna, Czyzewicz, Grzegorz, Orlov, Sergey V, Lewanski, Conrad R, Thomas, Michael, Bidoli, Paolo, Dakhil, Shaker, Gans, Steven, Kim, Joo-Hang, Grigorescu, Alexandru, Karaseva, Nina, Reck, Martin, Cappuzzo, Federico, Alexandris, Ekaterine, Sashegyi, Andreas, Yurasov, Sergey, Pérol, Maurice
Journal: Lancet
Publication Date: 2014-06-02
Authors: Pérol, Maurice, Winfree, Katherine B, Cuyun Carter, Gebra, Lin Cui, Zhanglin, Bowman, Lee, Garon, Edward B
Journal: Lung Cancer
Publication Date: 2019-03-02
Lead Sponsor: TILT Biotherapeutics Ltd.
Collaborators: Merck Sharp & Dohme LLC
Intervention / Treatment: BIOLOGICAL: KEYTRUDA®, BIOLOGICAL: TILT-123
Lead Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: Merck Sharp & Dohme LLC, National Cancer Institute (NCI), California Institute for Regenerative Medicine (CIRM), LUNGevity Foundation
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, BIOLOGICAL: Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
Lead Sponsor: Dynavax Technologies Corporation
Intervention / Treatment: DRUG: Approved Anti-PD-1 Inhibitor, DEVICE: Breath Actuated Nebulizer, DRUG: DV281, DRUG: DV281 (RP2D)